Norman Wolmark, M.D., presents memorial award lecture at SABCS

December 10, 2015

SAN ANTONIO - Norman Wolmark, MD, a world-renowned expert in breast cancer research, will present the William L. McGuire Memorial Lecture, "The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer," at the annual meeting of the San Antonio Breast Cancer Symposium on December 9, 2015. The symposium is being held December 7-12 in San Antonio. Dr. Wolmark was selected by the SABCS Executive and Planning Committees from nominations by distinguished researchers in breast cancer.

Established in 1992, the McGuire Lectureship commemorates the late Dr. William McGuire, who co-founded the SABCS in 1977, and his contributions to oncology. For more information, click here

Dr. Wolmark is a Professor at Drexel University School of Medicine, and Chairman of the NSABP Foundation. As Chairman of the National Surgical Adjuvant Breast and Bowel Project (NSABP), he has overseen the design and implementation of the group's breast and bowel cancer clinical trials since 1994. Since 2014, he has served as a Group Chair of NRG Oncology.

Dr. Wolmark is a member of numerous professional societies, including the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the American Surgical Association (ASA). He is a reviewer for the Journal of Clinical Oncology and the New England Journal of Medicine, and an editorial board member of the Journal of Women's Cancer and Clinical Breast Cancer. He serves on numerous boards and as an advisor to oncology programs, societies, and institutes throughout the United States, Canada, and Europe.

NRG Oncology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to